US2007207511A1PendingUtilityA1
Methods for identification, assessment, prevention, and therapy of cancer
Est. expiryMar 15, 2024(expired)· nominal 20-yr term from priority
G01N 33/57545G01N 33/5758C12N 2310/14G01N 2800/52C12N 15/113C12Q 2600/136C12Q 2600/158C12Q 1/6886
34
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the newly identified cancer therapeutic targets and biomarkers. These targets/biomarkers are overexpressed in carcinomas generally, and more specifically to adenocarcinoma and squamous cell carcinoma. The invention provides methods of diagnosis, characterization, and therapy of carcinoma based on the degree of overexpression of the targets/biomarkers.
Claims
exact text as granted — not AI-modified1 .- 20 . (canceled)
21 . A method of assessing whether a patient is afflicted with a carcinoma selected from the group consisting of colon cancer, breast cancer, lung cancer, ovarian cancer, cervical cancer and prostate cancer, the method comprising a) determining the amount of a polypeptide marker in a patient sample, wherein the marker is selected from Table 1; b) determining the normal amount of the polypeptide marker in a control non-cancerous sample; and c) comparing the amounts of the polypeptide marker between the patient sample and the control non cancerous sample, wherein a significant increase in the amount of the polypeptide marker in the patient sample from the normal level is an indication that the patient is afflicted with the carcinoma.
22 . The method of claim 21 , wherein the carcinoma is ovarian cancer.
23 . The method of claim 21 wherein the amount of the polypeptide marker is determined by binding the polypeptide marker with an antibody.
24 . The method of claim 23 wherein the antibody is derived from the full-length polypeptide marker or fragment thereof.
TABLE 1
SEQ ID NO
SEQ ID NO
(nucleotide
(amino acid
Gene Name
sequence)
sequence)
CDS
IRTKS: Insulin
1
2
217 . . . 1752
receptor tyrosine
kinase substrate
Solt:
3
4
265 . . . 1074
SoxLZ/Sox6-binding
protein Solt
Shax3: Snf7
5
6
179 . . . 880
homologue
associated
with Alix 3
WBSCR21: Williams
7
8
63 . . . 368
Beuren syndrome
chromosome
region 21
TABLE 2
SEQ ID NO
SEQ ID NO
(nucleotide
(nucleotide
sequence)
sequence)
Gene Name
Forward Primer
Reverse Primer
IRTKS: Insulin receptor tyrosine
9
10
kinase substrate
Solt: SoxLZ/Sox6-binding protein Solt
11
12
Shax3: Snf7 homologue associated with
13
14
Alix 3
WBSCR21: Williams Beuren syndrome
15
16
chromosome region 21Join the waitlist — get patent alerts
Track US2007207511A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.